Navigation Links
Express Scripts HealthBridge Pharma & Biotech to Provide Exclusive Specialty Pharmacy Services and Limited Distribution Services for Solesta®
Date:10/13/2011

ST. LOUIS, Oct. 13, 2011 /PRNewswire/ -- CuraScript, Inc., a wholly owned subsidiary of Express Scripts, Inc., is now the exclusive specialty pharmacy for patients using Solesta®, a product of Oceana Therapeutics Inc., under an agreement announced today. Part of Express Scripts HealthBridge Pharma & Biotech services, CuraScript SD Specialty Distribution will be one of two national distributors responsible for delivering Solesta to healthcare providers.

Solesta is the only nonsurgical treatment approved by the Food and Drug Administration for patients who fail conservative therapy for fecal (bowel) incontinence. A biocompatible tissue-bulking agent, Solesta is an injectable gel administered in an outpatient setting without the need for anesthesia. Oceana Therapeutics has exclusive rights to market, sell and distribute Solesta, a registered trademark of the international medical device company Q-Med AB.

About HealthBridge Pharma & BiotechHealthBridge Pharma & Biotech provides a suite of services offering pharmaceutical and biotech companies a single solution approach to patient care. These services include: CuraScript SP Specialty Pharmacy, CuraScript SD Specialty Distribution, Freedom Fertility Pharmacy, risk evaluation and mitigation strategies (REMS), reimbursement, patient assistance programs (PAP), data and sales reporting, enhanced account services, and customized adherence programs.

As a service of HealthBridge Pharma & Biotech, CuraScript SP Specialty Pharmacy is a wholly owned subsidiary of Express Scripts. CuraScript manages the largest number of exclusive Pharma/Biotech programs in the industry and has been involved in nearly every specialty product launch over the last eight years. CuraScript services more than 1,800 plan sponsors that cover tens of millions of Americans.

CuraScript SD Specialty Distribution, an Express Scripts subsidiary, is a premier provider of comprehensive distribution solutions for physicians' offices, practices, surgery centers, hospitals and other clinical settings.

More information can be found at http://TheHealthBridgeSolution.com/.

About Express ScriptsExpress Scripts, Inc., one of the largest pharmacy benefit management companies in North America, is leading the way toward creating better health and value for patients through Consumerology®, the advanced application of the behavioral sciences to healthcare. This approach is helping millions of members realize greater healthcare outcomes and lowering cost by assisting in influencing their behavior. Headquartered in St. Louis, Express Scripts provides integrated PBM services including network-pharmacy claims processing, home delivery services, specialty benefit management, benefit-design consultation, drug-utilization review, formulary management, and medical and drug data analysis services. The company also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services. More information can be found at http://www.express-scripts.com/ and http://www.consumerology.com/. Media Contact:

Thom Gross314.684.6321rtgross@express-scripts.com
'/>"/>

SOURCE Express Scripts
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Express Scripts Announces Revised 2011 Financial Guidance
2. ChemoMetec and De Novo Software to Co-market NucleoCounter® NC-3000™ and FCS Express 4 Image Cytometry Software
3. Transcriptome Viewer - Comprehensive Genome-wide Map of Human Gene Expression Activity Released for Public by MediSapiens
4. Merger of Express Scripts and Medco Health Solutions Will Address the Bipartisan Mandate for Safer, More Affordable, Higher Quality Healthcare
5. Molecular Devices Announces ImageXpress Micro XL High-Content Screening System
6. Express Scripts to Present at Investor Conferences in September
7. Generex Subsidiary Antigen Express Provides Update on Phase 2 Breast Cancer Immunotherapy Program
8. Express Scripts and Medco Health Solutions Sign Definitive Merger Agreement; Medco Shareholders to Receive $29.1 Billion
9. Express Scripts Announces Second Quarter 2011 Earnings Conference Call
10. Express Scripts Strives to Make Prescription Drugs Affordable and Accessible to American Families
11. Generex Announces Appointment of CEO for Post-Spinout Antigen Express
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... Research and Markets has announced the addition of the "Microplate Instrumentation ... ... comprehensive analytics for the US, Canada , ... , Latin America , and Rest of World. Annual ... a six-year historic analysis is provided for these markets. Market data and ...
(Date:3/24/2017)... March 23, 2017  Provectus Biopharmaceuticals, Inc. (OTCQB: ... a clinical-stage oncology and dermatology biopharmaceutical company, today ... Commitment Term Sheet (the "Definitive Financing") it entered ... the Company,s stockholders, who are referred to in ... Form 8-K filed with the Securities and Exchange ...
(Date:3/23/2017)... The key factors driving the growth ... accelerating economic growth and increasing healthcare expenditure. Some of the ... expectancy of ESRD patients, rising demand for home PD treatment ... of the market is hindered by high treatment costs and ... ...
Breaking Medicine Technology:
(Date:3/24/2017)... ... 24, 2017 , ... Infectious disease affects billions of people ... States, it’s a threat that is constantly changing and evolving. Mediaplanet's “Fighting Infection” ... strategies for the healthcare community to help decrease the number of completely preventable ...
(Date:3/24/2017)... ... 2017 , ... The iaedp Foundation, the premier provider of educational programs and ... from the full spectrum of disordered eating, announced today that the 2017 Symposium set ... 50 states and several countries converged on the Green Valley Resort in Las Vegas. ...
(Date:3/24/2017)... , ... March 24, 2017 , ... ... announce that they are now offering treatments for sleep apnea and TMJ at ... offices. Sleep apnea , specifically the obstructive type, is increasingly being treated ...
(Date:3/24/2017)... , ... March 24, 2017 , ... ... year of enhancements, upgrading their training and leads programs. , In February, 2017, ... for elite sales agents, Performance Partners is designed to teach how to maximize ...
(Date:3/24/2017)... ... March 24, 2017 , ... “The Communion ... real people of God in congregations across the United States. “The Communion ... ordained in 1964 who has served congregations in seven states throughout his long ...
Breaking Medicine News(10 mins):